PHUONG LY: Open Payments
NPI 1922696129 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$694 in 33 payments from 15 companies in 2025. Trend: 2023 $138 · 2024 $29 · 2025 $694
Food & beverage: $694
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $106 |
| Celltrion USA Inc. | 4 | $93 |
| ABBVIE INC. | 5 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| Janssen Biotech, Inc. | 3 | $59 |
| Novo Nordisk Inc | 2 | $49 |
| Madrigal Pharmaceuticals | 2 | $49 |
| Intercept Pharmaceuticals, Inc. | 2 | $42 |
| Aimmune Therapeutics, Inc. | 1 | $27 |
| Lucid Diagnostics Inc. | 1 | $23 |
Products named: XIFAXAN, VEGZELMA, TREMFYA, CREON, Wegovy, REZDIFFRA, ENTYVIO, OCALIVA.
Industry payments across FL — which companies pay providers there.
